Work

Nanotechnology in Lung Cancer Therapeutics: A Narrative Review

Year: 2023

Type: review

Abstract: To date, cancer continues to be one of the biggest challenges for medical science. Nanotechnology has enabled us to overcome some of the limitations of conventional treatment in lung cancer therapeutics. Recently, US Food and Drug Administration (FDA) has approved certain nanomedicines for clinical administration against lung cancer. This article presents a narrative review of approved nanomedicines in lung cancer with a special focus on the results of recently concluded and ongoing clinical trials. The limitations associated with using nanomaterials as anti-lung cancer therapeutic agents and the possible mechanisms to overcome these limitations are also discussed.

Source: Cureus

DOI: 10.7759/cureus.34245

Authors: Vaibhav Koutu, Manish Gupta, Saikat Das, Deepak K Rawat, Vipin Kharade, Rajesh K Pasricha

Institution: All India Institute of Medical Sciences Bhopal

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Department of Science and Technology, Ministry of Science and Technology, India